New drug approval: Nivolumab plus Ipilimumab/chemotherapy in esophageal squamous-cell carcinoma

被引：0
|
作者：
Chalah, Celine [1 ]
Neuzillet, Cindy [2 ]
机构：
[1] Hop St Antoine, Serv Gastroenterol, 184 Rue Faubourg St Antoine, F-75012 Paris, France
[2] Inst Curie Site St Cloud, 35 Rue Dailly, F-92210 St Cloud, France
来源：
BULLETIN DU CANCER | 2022年 / 109卷 / 10期
关键词：
Immune therapy; Anti-PD1; Anti-CTLA4; Esophageal cancer; CHEMOTHERAPY; JUNCTION; PLACEBO;
D O I：
10.1016/j.bulcan.2022.05.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：990 / 991
页数：2
相关论文
共 50 条
  • [21] Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck-Reply
    Harrington, Kevin J.
    Haddad, Robert
    JAMA ONCOLOGY, 2024, 10 (01) : 144 - 145
  • [22] CHEMOTHERAPY VERSUS CHEMOTHERAPY PLUS RADIOTHERAPY IN THE TREATMENT OF TONSILLAR SQUAMOUS-CELL CARCINOMA IN THE DOG
    BROOKS, MB
    MATUS, RE
    LEIFER, CE
    ALFIERI, AA
    PATNAIK, AK
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 1988, 2 (04) : 206 - 211
  • [23] Fulminant Myocarditis for Non-small-cell Carcinoma of the Lung with Nivolumab and Ipilimumab Plus Chemotherapy
    Nishimura, Tomoka
    Ninomiya, Kiichiro
    Nakashima, Mitsutaka
    Akagi, Satoshi
    Kuribayashi, Tadahiro
    Higo, Hisao
    Hotta, Katsuyuki
    Maeda, Yoshinobu
    Ito, Hiroshi
    Kiura, Katsuyuki
    INTERNAL MEDICINE, 2023, 62 (09) : 1319 - 1322
  • [24] CHEMOTHERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE OROPHARYNX
    ARNHOLDSCHNEIDER, M
    POLYZOIDIS, T
    HNO, 1987, 35 (11) : 468 - 471
  • [25] CHEMOTHERAPY OF SQUAMOUS-CELL CARCINOMA OF THE CERVIX
    LLORENS, AS
    OBSTETRICS AND GYNECOLOGY, 1980, 55 (03): : 373 - 375
  • [26] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    Ferris, R. L.
    Blumenschein, G., Jr.
    Fayette, J.
    Guigay, J.
    Colevas, A. D.
    Licitra, L.
    Harrington, K.
    Kasper, S.
    Vokes, E. E.
    Even, C.
    Worden, F.
    Saba, N. F.
    Iglesias Docampo, L. C.
    Haddad, R.
    Rordorf, T.
    Kiyota, N.
    Tahara, M.
    Monga, M.
    Lynch, M.
    Geese, W. J.
    Kopit, J.
    Shaw, J. W.
    Gillison, M. L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1856 - 1867
  • [27] Nivolumab for recurrent squamous-cell carcinoma of the head and neck
    British Dental Journal, 2016, 221 (10) : 632 - 632
  • [28] Nivolumab plus ipilimumab in advanced renal-cell carcinoma
    Gunjur, Ashray
    LANCET ONCOLOGY, 2018, 19 (05): : E232 - E232
  • [29] Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
    Choueiri, Toni K.
    Powles, Thomas
    Albiges, Laurence
    Burotto, Mauricio
    Szczylik, Cezary
    Zurawski, Bogdan
    Ruiz, Eduardo Yanez
    Maruzzo, Marco
    Zaizar, Alberto Suarez
    Fein, Luis E.
    Schutz, Fabio A.
    Heng, Daniel Y. C.
    Wang, Fong
    Mataveli, Fabio
    Chang, Yu-Lin
    van Kooten Losio, Maximiliano
    Suarez, Cristina
    Motzer, Robert J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (19): : 1767 - 1778
  • [30] Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
    Gervaso, Lorenzo
    Fazio, Nicola
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (05): : 476 - 477
12345